Relationships between health professionals and industry: Maintaining a delicate balance

Australian Prescriber

Volumn 30, Issue 6, 2007, Pages 150-153

  Komesaroff, Paul A ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL AUSTRALASIAN COLLEGE OF PHYSICIANS   (Australia)

Author keywords

Drug promotion; Drug regulation; Ethics

Indexed keywords

DECISION MAKING; DRUG INDUSTRY; DRUG MARKETING; ETHICS; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HEALTH PROMOTION; HUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PUBLIC HEALTH; REVIEW;

EID: 36849002764     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2007.089     Document Type: Review

References (26)

1. McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, Newby D, et al. Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. Intern Med J 2006;36:571-8.
2. Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med 2003;163:2213-8.
3. Halperin EC, Hutchison P, Barrier RC Jr. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Int J Radiat Oncol Biol Phys 2004;59:1477-83.
4. Haayer F. Rational prescribing and sources of information. Soc Sci Med 1982;16:2017-23.
5. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ 1993;149:1401-7.
6. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000;283:373-80.
7. Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med 1988;26:1183-9.
8. Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994;271:684-9.
9. Rutledge P, Crookes D, McKinstry B, Maxwell SR. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey. Pharmacoepidemiol Drug Saf 2003;12:663-7.
10. Agrawal S. Pharmaceutical industry and sponsorship of delegates for national conferences. Indian Pediatr 2002;39:445-8.
11. Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, et al. Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience. Med J Aust 2005;182:557-60.
12. Henry D, Doran E, Kerridge I, Hill S, McNeill PM, Day R. Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry. Arch Intern Med 2005;165:2493-6.
13. Bero LA, Rennie D. Influences on the quality of published drug studies. Int J Technol Assess Health Care 1996;12:209-37.
14. Illich I. Limits to medicine. London: Marion Boyars; 1977.
15. Moynihan R. The making of a disease: female sexual dysfunction. BMJ 2003;326:45-7.
16. Angell M. The truth about the drug companies: how they deceive us and what to do about it. New York: Random House; 2004.
17. Moynihan R, Cassells A. Selling sickness: how the drug companies are turning us all into patients. Sydney: Allen & Unwin; 2005.
18. John le Carre. The constant gardener. New York: Simon and Schuster; 2001.
19. Working together. The guide. A guide to relationships between health consumer organisations and pharmaceutical companies. Consumers' Health Forum of Australia and Medicines Australia. 2005. http://www.chf.org.au/Docs/Downloads/ 360_guide_for_relationships.pdf [cited 2007 Nov 12]
20. Medicines Australia. Code of Conduct. 15th ed. 2006. Amended Aug 2007. http://www.medicinesaustralia.com.au [cited 2007 Nov 12]
21. Medicines Australia Code of Conduct: breaches. Aust Prescr 2007;30:151-3.
22. Bickerstaffe R, Brock P, Husson JM, Rubin I, Bragman K, Paterson K, et al. Ethics and pharmaceutical medicine - the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK. Int J Clin Pract 2006;60:242-52.
23. Komesaroff PA, Bach MA, Danoff A, Grumbach MM, Kaplan S, Lakoski JM, et al. The Endocrine Society Ethics Advisory Committee: ethical aspects of conflicts of interests, October 2003. Endocrinology 2004;145:3032-41.
24. Komesaroff P, Carney S, La Brooy J, Tattersall M, Greenberg P. Guidelines for ethical relationships between physicians and industry. 3rd ed. Sydney: Royal Australasian College of Physicians; 2006. http://www.racp.edu.au [cited 2007 Nov 12]
25. Royal Australian College of General Practitioners. General practitioners and commercial sponsorship. http://www.racgp.org.au/guidelines [cited 2007 Nov 12]
26. Pharmaceutical Society of Australia. Gifts from pharmaceutical companies. http://www.psa.org.au [cited 2007 Nov 12]